Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Topical ophthalmic formulations of endothelin receptor antagonists

Topical ophthalmic formulations of endothelin receptor antagonists

US Patent 10716750 · Granted Jul 21, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2024
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2024
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2021
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodege2021
Sex hormone-binding globulin for use as a medicament2020
Sex hormone-binding globulin for use as a medicament2020
SOCS1-derived peptide for use in chronic complications of diabetes2020
SOCS1-derived peptide for use in chronic complications of diabetes2020
Peptides for use in the topical treatment of retinal neurodegenerative diseases,2017
Peptides for use in the topical treatment of retinal neurodegenerative diseases,2017
Administering antibodies or fragments thereof which bind hemopexin for the treat2017
Administering antibodies or fragments thereof which bind hemopexin for the treat2017